71773-050 : Xerava 50 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: | 71773-050 |
Labeler: | Tetraphase Pharmaceuticals, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Xerava |
Dosage Form: | Intravenous Injection, Powder, Lyophilized, for Solution |
Application #: | NDA211109 |
Rev. Date: |
NDC Package Codes:
- 71773-050-05: 1 VIAL, GLASS IN 1 CARTON (71773‑050‑05) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL, GLASS
- 71773-050-12: 12 VIAL, GLASS IN 1 CARTON (71773‑050‑12) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL, GLASS
Active Ingredients:
- Eravacycline Dihydrochloride
Dosage Strength:
- 50 mg
Pharmaceutical Classes:
- Tetracycline-class Antibacterial [EPC]
- Tetracyclines [CS]
Related Products:
Based on records with the same trade name.- 71773-100 Xerava 100 mg Intravenous Injection, Powder, Lyophilized, for Solution by Tetraphase Pharmaceuticals, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 71772-486Next: 71773-100 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.